Body shape and fat measurement in people with HIV
Part of Immune system & allergy, Infections clinical trials.
This study compares different ways to measure body fat and shape in people living with HIV. It aims to find better tools to assess health risks related to fat distribution.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with HIV.
- You have been on the same HIV medication for at least 6 months.
- You are not pregnant.
- You do not have an implantable cardioverter or pacemaker.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with HIV who also have fatty liver disease and checks their health over time. It may help by improving monitoring and care planning, especially using ultrasound scans and regular follow-up.
This study looks at how hidden fat deep inside the body (ectopic fat) might increase heart attack risk in people living with HIV. By joining, you will help researchers understand this link and find better ways to protect your heart.
This study measures how older adults’ muscles use energy and how easily they tire during activity. It includes both people with HIV (with stable treatment and an undetectable viral load) and people without HIV to better understand differences in fatigue.
This study looks at how a structured exercise program affects the heart and blood flow in people living with HIV. It may help your care team understand who benefits most from exercise and how to do it safely.
This trial compares two different daily pill combinations for people newly starting HIV treatment who are overweight or have obesity. It aims to see which one works better for controlling the virus and managing weight.
This study looks back at people with HIV to understand how often and why heart problems happen. It may help doctors better track heart risk and complications over time.
Hear when a new HIV/AIDS trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.